SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited announced the passing of key resolutions at their Annual General Meeting held on June 28, 2024, with overwhelming support for the adoption of audited financial statements and re-election of directors, alongside a special resolution to amend the company’s articles of association. However, resolutions to extend the mandate to issue additional shares faced opposition, with less than 50% approval. Shareholders also granted a mandate to repurchase shares and endorsed the reappointment of PricewaterhouseCoopers as the auditor.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.